ALPI Solutions attended the Biostatistics Symposium of Southern California (BSSC), where key discussions focused on the intersection of clinical trials, artificial intelligence, and regulatory strategy.
The event highlighted how data-driven approaches and AI are transforming decision-making in drug development — from study design to regulatory submissions.
These insights reinforce the growing need for integrated expertise in analytics, regulatory affairs, and strategic execution across the pharmaceutical industry.
